PROFESSIONAL EDITION

The largest community of pharma leaders

Be part of our community by subscribing to our newsletters! Follow the steps below.

1. Subscribe to our Announcement Newsletter. You will receive our news about what do you need to know about our work and the resources available for you. You need to confirm your subscription by email (check your email box and confirm your subscription)

2. Choose your favorite writer. We constantly look for the top minds on the pharmaceutical marketing industry. You can subscribe to their article on their pages and receive every article on your inbox. 

3. Choose the Newsletter that better fits you needs. We recommend the Editor’s pick to receive everything you need to know in one weekly email. 

4. All our newsletters needs to be confirmed by email. After you subscribe on our webpage, you will receive an email asking for your confirmation by clicking a link. Click that link if you want to receive the newsletter. If you don’t receive the email, check your spam box and add our email to your safe sender list. If you address belongs to a company, you may need to forward your confirmation email to your tech department to ask them to add our domain to your company safe sender list. 

You can start here by subscribing to our main Newsletter. Confirm your subscription by clicking CONFIRM on the email you will receive after complete the subscription form.

Don’t forget to check for our other newsletters! Check this page for several options we have for all our users!

NEWSLETTER ANNOUCEMENTS




TPMG FEATURED WRITER NEWSLETTER




Top 10 Tips for Creating Company Culture in a...

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may...

Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Natalie Yeadon´s Newsletter




Top 10 Tips for Creating Company Culture in a...

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may...

Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Tommaso Salanitri´s Newsletter




“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

EDITOR´S PICK




Ninety Percent of Large Pharma Companies Initiated Artificial Intelligence/Machine...

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS...

Walgreens Statement in Support of President-Elect Biden’s COVID-19 Update

Walgreens Statement in Support of President-Elect Biden’s COVID-19 Update January 15, 2021 09:10 PM Eastern Standard Time DEERFIELD, Ill.--(BUSINESS WIRE)--Following President-elect...

Uber and Moderna Collaborate to Raise Awareness and Increase...

Companies aim to build confidence in COVID-19 vaccines via Uber’s global network of riders and drivers January 12, 2021 08:00...

Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Swissmedic,...

Lack of Global Cooperation Is Crippling the COVID-19 Response:...

LOS ANGELES--(BUSINESS WIRE)--All through 2020, the world held its collective breath in anticipation of the first COVID-19 vaccines, but...

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma...

● Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients ● Scientists from...

LOOK WHO IS ON THE MOVE!




Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients...

Talaris Therapeutics Adds Two Experienced Biotechnology Executives to its...

BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the...

Ipsen Appoints Gwenan White as Executive Vice President, Communications...

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Gwenan White as Executive Vice President,...

CIRCULOGENE Appoints Stephen Unger Chief Financial Officer

BIRMINGHAM, Ala.--(BUSINESS WIRE)-- #cancer--CIRCULOGENE appoints life sciences industry investment and finance veteran Stephen Unger as Chief Financial Officer. Source...

Nilesh Patel Joins Cellanyx Board of Directors

BEVERLY, Mass.--(BUSINESS WIRE)--Nilesh Patel, a private equity exec with a background in strategy, operations, analytics and corporate finance joins...

SwanBio Therapeutics Appoints Alison Lawton to Board of Directors

PHILADELPHIA--(BUSINESS WIRE)--SwanBio Therapeutics (SwanBio), a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological...

INDUSTRY NEWS




Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) Source Business Wire Health: Pharmaceutical NewsRead More

Prosetta Biosciences Announces Novel Solution to COVID-19 Crisis

SAN FRANCISCO--(BUSINESS WIRE)--Prosetta Biosciences, a San Francisco biotechnology company, has developed novel small-molecule drugs that research indicates are effective...

New Vaccination Cart from Ergotron Supports COVID-19 Vaccine Distribution...

ST. PAUL, Minn.--(BUSINESS WIRE)--Ergotron’s new Vaccination Cart empowers safe and efficient COVID-19 vaccination workflows in clinic spaces and in...

Aptinyx Announces Publication of Review Article Highlighting Preclinical Data...

EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...

Capital Rx Partners with VaxAtlas to Streamline COVID-19 Vaccination...

NEW YORK--(BUSINESS WIRE)--Capital Rx (https://www.cap-rx.com/), the fastest-growing pharmacy benefit manager in the U.S., today announced a partnership with VaxAtlas,...

Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness with...

STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA...

REGULATORY AFFAIRS




Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) Source Business Wire Health: Pharmaceutical NewsRead More

Applied DNA Promotes Judith Murrah to Chief Operating Officer

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction...

U.S. Food and Drug Administration Accepts for Priority Review...

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--U.S. FDA Accepts for Priority Review Application for Opdivo as Adjuvant Therapy for Patients w/Resected...

ENHERTU® Approved in the EU for the Treatment of...

TOKYO & MUNICH--(BUSINESS WIRE)--ENHERTU® Approved in the EU for the Treatment of HER2 Positive Metastatic Breast Cancer Source Read...

Biologics License Application for Narsoplimab in HSCT-TMA Accepted for...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) announced today that the Biologics License Application (BLA) for narsoplimab for the treatment of...

Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan...

Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan Drug Designations for TSHA-105 for the Treatment of Epilepsy Caused...

MEDICAL DEVICES




EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that...

New Alcon Innovations in Intraocular Lenses, Digital Health Solutions...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, will highlight a...

Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development...

BOSTON & LONDON--(BUSINESS WIRE)--Synthace Ltd and Ipsen, a global biopharmaceutical company focused on innovation and specialty care, have partnered...

World’s Leading Home Improvement Retailer Battling COVID-19 Impact with...

MIDDLETOWN, Conn.--(BUSINESS WIRE)--Reality Interactive, a leading retail technology design firm and digital agency in Middletown, Connecticut, announced the launch...

PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency...

Optomec Delivers 3D Electronics Printer for Medical Device Production

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Optomec has delivered a new industrialized 3D Printed Electronics system to a major US healthcare manufacturer, where...

HOSPITAL NEWS




Turnstone Biologics Acquires Novel Cell Therapy Platform

NEW YORK--(BUSINESS WIRE)--Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio...

Mayo Clinic Laboratories and American Hospital Dubai Announce Strategic...

Mayo Clinic Laboratories and American Hospital Dubai Announce Strategic Partnership American Hospital Dubai (Photo: AETOSWire) January 17, 2021 12:25 PM...

City of Hope Scientists Have Developed a Precision Medicine...

City of Hope Scientists Have Developed a Precision Medicine Tool That Predicts If Chemotherapy Will Produce Debilitating Side Effects...

Veristat Supported Marketing Applications for 10% of All FDA...

Veristat Supported Marketing Applications for 10% of All FDA Novel Drug Approvals in 2020 Strengthening its Track Record of Successful...

Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore...

Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus --...

AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM...

AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development January 11, 2021 06:59 PM Eastern...

CLINICAL TRIALS




Forma Therapeutics Announces First Patient Dosed in Phase 1...

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics announces the first patient dosed in Phase 1 clinical trial evaluating FT-7051 in metastatic castration-resistant...

Forma Therapeutics Announces First Patient Dosed in Phase 1...

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics announces the first patient dosed in Phase 1 clinical trial evaluating FT-7051 in metastatic castration-resistant...

Aptorum Group Receives Clearance from Health Canada to Initiate...

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)-- #biopharmaceutical--Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) (“Aptorum Group” or...

 ImmunityBio Announces Phase I Trial of COVID-19 Vaccine Candidate...

ImmunityBio Announces Phase I Trial of COVID-19 Vaccine Candidate in South Africa as New Variants of SARS-CoV-2 Spread    Plans to...

Apnimed Announces First Patient Dosed in a Second Phase...

Apnimed Announces First Patient Dosed in a Second Phase 2 Clinical Trial with AD109, a Disease Modifying Candidate for...

NIH and PhysIQ Complete Initial Phase of COVID-19 Digital...

CHICAGO--(BUSINESS WIRE)--The National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National...